The most important financial indicators for the company Hyperion Medical Srl - Unique Identification Number 15589029:
sales in 2023 was
253.002
euro, registering a net profit of
205.207
euro and having an average number of
2
employees.
Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 9.2%, from 232.351 euro in the year 2022, to 253.002 euro in 2023.
The Net Profit increased by 18.940 euro, from 186.833 euro in 2022, to 205.207 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Hyperion Medical Srl - CUI 15589029
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
31.441
30.313
28.156
25.863
23.605
22.664
21.782
20.903
20.570
20.112
Current Assets
51.124
73.155
66.274
70.437
64.268
99.960
135.038
137.495
183.683
205.193
Inventories
3.483
4.972
4.922
4.881
4.578
4.490
4.405
3.836
4.446
4.432
Receivables
2.132
6.175
7.334
7.233
12.695
4.471
3.066
3.630
138.245
38.361
Cash
45.509
62.008
54.018
58.323
46.994
90.999
127.567
130.029
40.992
162.400
Shareholders Funds
78.987
97.414
87.798
91.399
83.087
117.879
153.645
155.222
202.619
221.019
Social Capital
223
225
223
219
215
211
207
202
203
202
Debts
3.578
6.054
6.632
4.901
4.786
4.745
3.175
3.176
1.634
4.285
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"8622 - 8622"
CAEN Financial Year
8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
205.193 euro in 2023 which includes Inventories of
4.432 euro, Receivables of
38.361 euro and cash availability of
162.400 euro.
The company's Equity was valued at
221.019 euro, while total Liabilities amounted to
4.285 euro.
Equity increased by 19.014 euro, from 202.619 euro in 2022, to 221.019 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Hyperion Medical Srl